Back to companies

Shanghai Fosun Pharmaceutical (Group) Co Ltd: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

View up-to-date information on Shanghai Fosun Pharmaceutical (Group) Co Ltd patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
CN110177788B Grant 作为bcl-2选择性凋亡诱导剂的化合物 A61K45/06; A61P35/00; C07D471/04 March 24, 2023
ES2766498T5 Grant Cierto inhibidor de proteína quinasa A61K31/506; A61K31/5383; A61K45/06; A61P29/00; A61P35/00; C07D401/14; C07D403/14; C07D471/14; C07D487/04; C07D487/10; C07D519/00 November 18, 2022
BR112016027679B1 Grant Inibidores de proteína quinase, seu usos e seus métodos de fabricação, kit e composição farmacêutica A61K2300/00; A61K31/519; A61K31/53; A61K31/5377; A61K45/06; A61P29/00; A61P35/00; A61P43/00; C07D401/12; C07D401/14; C07D403/12; C07D403/14; C07D487/04; C07D491/04; C07D491/048; C07D495/04; C07D519/00 October 25, 2022
DK3288931T4 Application Visse proteinkinaseinhibitorer A61K31/506; A61K31/5383; A61K45/06; A61P29/00; A61P35/00; C07D401/14; C07D403/14; C07D471/14; C07D487/04; C07D487/10; C07D519/00 October 24, 2022
EP3288931B2 Grant Bestimmter proteinkinaseinhibitor A61K31/506; A61K31/5383; A61K45/06; A61P29/00; A61P35/00; C07D401/14; C07D403/14; C07D471/14; C07D487/04; C07D487/10; C07D519/00 July 20, 2022
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Register your interest

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer